Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization

Publisher： Karger

E-ISSN： 1423-0232|89|3|167-174

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.3, 2015-05, pp. : 167-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin

By  

Case Reports in Oncology, Vol. 4, Iss. 2, 2011-06 ,pp. : 327-335

Karger

Access to resources Recommend Favorite

Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma

By Kim J. S.   Kwak B. K.   Shim H. J.   Lee Y. C.   Baik H. W.   Lee M. J.   Han S-M.   Son S. H.   Kim Y. B.   Tokura S.   Lee B. M.  

Journal of Microencapsulation, Vol. 24, Iss. 5, 2007-01 ,pp. : 408-419

Informa Healthcare

Access to resources Recommend Favorite

Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Recent Progression and Perspective

By  

Oncology, Vol. 84, Iss. 1, 2013-02 ,pp. : 28-33

Karger

Access to resources Recommend Favorite

Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma

By  

Oncology, Vol. 84, Iss. 1, 2013-02 ,pp. : 40-43

Karger

Access to resources Recommend Favorite